Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Melatonin 2mg modified-release tablets
0401010ADAAAAAA
|
Melatonin | Melatonin | Central Nervous System | 142,754 |
|
Melatonin 1mg/ml oral solution sugar free
0401010ADAACZCZ
|
Melatonin | Melatonin | Central Nervous System | 28,007 |
|
Melatonin 2mg tablets
0401010ADAABKBK
|
Melatonin | Melatonin | Central Nervous System | 19,094 |
|
Melatonin 3mg tablets
0401010ADAACYCY
|
Melatonin | Melatonin | Central Nervous System | 9,854 |
|
Melatonin 2mg capsules
0401010ADAAAEAE
|
Melatonin | Melatonin | Central Nervous System | 8,122 |
|
Melatonin 4mg tablets
0401010ADAACPCP
|
Melatonin | Melatonin | Central Nervous System | 5,908 |
|
Melatonin 1mg modified-release tablets
0401010ADAACUCU
|
Melatonin | Melatonin | Central Nervous System | 5,225 |
|
Melatonin 3mg capsules
0401010ADAABRBR
|
Melatonin | Melatonin | Central Nervous System | 4,079 |
|
Melatonin 5mg modified-release tablets
0401010ADAACVCV
|
Melatonin | Melatonin | Central Nervous System | 3,372 |
|
Melatonin 2mg/5ml oral solution
0401010ADAABYBY
|
Melatonin | Melatonin | Central Nervous System | 2,863 |
|
Melatonin 1mg tablets
0401010ADAAAIAI
|
Melatonin | Melatonin | Central Nervous System | 2,377 |
|
Melatonin 5mg tablets
0401010ADAABLBL
|
Melatonin | Melatonin | Central Nervous System | 2,339 |
|
Melatonin 5mg capsules
0401010ADAABSBS
|
Melatonin | Melatonin | Central Nervous System | 1,305 |
|
Melatonin 10mg/5ml oral suspension
0401010ADAACECE
|
Melatonin | Melatonin | Central Nervous System | 898 |
|
Melatonin 10mg/5ml oral solution
0401010ADAACDCD
|
Melatonin | Melatonin | Central Nervous System | 798 |
|
Melatonin 5mg/5ml oral solution
0401010ADAADADA
|
Melatonin | Melatonin | Central Nervous System | 631 |
|
Melatonin 10mg capsules
0401010ADAAAKAK
|
Melatonin | Melatonin | Central Nervous System | 611 |
|
Melatonin 2.5mg/5ml oral solution
0401010ADAACFCF
|
Melatonin | Melatonin | Central Nervous System | 533 |
|
Melatonin 2mg/5ml oral suspension
0401010ADAABZBZ
|
Melatonin | Melatonin | Central Nervous System | 468 |
|
Melatonin 3mg/5ml oral solution
0401010ADAACACA
|
Melatonin | Melatonin | Central Nervous System | 463 |
|
Melatonin 5mg/5ml oral suspension
0401010ADAADEDE
|
Melatonin | Melatonin | Central Nervous System | 282 |
|
Melatonin 2mg/ml oral solution sugar free
0401010ADAADFDF
|
Melatonin | Melatonin | Central Nervous System | 281 |
|
Melatonin 3mg modified-release capsules
0401010ADAAAJAJ
|
Melatonin | Melatonin | Central Nervous System | 179 |
|
Melatonin 2.5mg/5ml oral suspension
0401010ADAACGCG
|
Melatonin | Melatonin | Central Nervous System | 177 |
|
Melatonin 1mg capsules
0401010ADAABQBQ
|
Melatonin | Melatonin | Central Nervous System | 168 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.